Athersys Inc
ATHX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$330.64K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $330,642.00 |
|---|---|
| Enterprise Value | $18.04 Million |
| Earnings per Share | $-5.7 |
| Beta | -0.9 |
| Outstanding Shares | 24,492,000 |
Return
| Return on Equity | 102.73% |
|---|---|
| Return on Assets | -503.33% |
| Return on Invested Capital | 133.67% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 222.69 |
| Enterprise Value to EBIT | -0.43 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | -0.51 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Athersys Inc
CEO: Gil Van Bokkelen
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy...